These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 15069117)

  • 21. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
    Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
    Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
    Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
    Cancer Res; 2007 Aug; 67(16):7923-8. PubMed ID: 17699799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Insulin-Like Growth Factor 1-Related Biomarkers and Risk of Lethal Prostate Cancer.
    Ma C; Wang Y; Wilson KM; Mucci LA; Stampfer MJ; Pollak M; Penney KL
    JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35047751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B; Liu DB; Zhang X; DU LL; Han CZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.
    Palmqvist R; Hallmans G; Rinaldi S; Biessy C; Stenling R; Riboli E; Kaaks R
    Gut; 2002 May; 50(5):642-6. PubMed ID: 11950809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
    J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers.
    Ho GYF; Zheng SL; Cushman M; Perez-Soler R; Kim M; Xue X; Wang T; Schlecht NF; Tinker L; Rohan TE; Wassertheil-Smoller S; Wallace R; Chen C; Xu J; Yu H
    J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 27071409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
    Cust AE; Allen NE; Rinaldi S; Dossus L; Friedenreich C; Olsen A; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Chang-Claude J; Boeing H; Schulz M; Benetou V; Trichopoulou A; Trichopoulos D; Palli D; Berrino F; Tumino R; Mattiello A; Vineis P; Quirós JR; Agudo A; Sánchez MJ; Larrañaga N; Navarro C; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Bingham S; Khaw KT; Key T; Slimani N; Riboli E; Kaaks R
    Int J Cancer; 2007 Jun; 120(12):2656-64. PubMed ID: 17285578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting glucose is a risk factor for breast cancer: a prospective study.
    Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era.
    Platz EA; Pollak MN; Leitzmann MF; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Causes Control; 2005 Apr; 16(3):255-62. PubMed ID: 15947877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.
    Ma J; Li H; Giovannucci E; Mucci L; Qiu W; Nguyen PL; Gaziano JM; Pollak M; Stampfer MJ
    Lancet Oncol; 2008 Nov; 9(11):1039-47. PubMed ID: 18835745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
    Limburg PJ; Stolzenberg-Solomon RZ; Vierkant RA; Roberts K; Sellers TA; Taylor PR; Virtamo J; Cerhan JR; Albanes D
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1514-21. PubMed ID: 17162243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands).
    Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Rinaldi S; Riboli E; Grobbee DE; Peeters PH
    Cancer Causes Control; 2001 Dec; 12(10):951-8. PubMed ID: 11808715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
    Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
    J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.